Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA) | Markets Insider

Retrieved on: 2025-01-21 16:55:21

Tags for this article:

Click the tags to see associated articles and topics

Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA) | Markets Insider. View article details on hiswai:

Excerpt

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Moderna (MRNA – Research Report), with a price target .

Article found on: markets.businessinsider.com